Literature DB >> 8589262

Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.

D Clarke1, O Katoh, R V Gibbs, S D Griffiths, M Y Gordon.   

Abstract

We have investigated the binding of interleukin 7 (IL-7) to sulfated glycosaminoglycans and evaluated its biological consequences. IL-7 binds to heparin and heparan sulfate, to a lesser extent to dermatan sulfate and does not bind to chondroitin sulfate. It was eluted from heparin by 0.3-0.6 M NaCl and from heparan sulfate by < 0.3 M NaCl. We also measured the affinity of IL-7 for heparin using an affinity co-electrophoresis method and found an affinity of 25 nM. In spite of these findings, IL-7 does not bind to the S17 cell line which supports lymphopoiesis. However, addition of heparin to cultures of an IL-7-dependent pre-B cell line (2E8) inhibited IL-7-stimulated proliferation and IL-7 complexed with heparin was more resistant than free IL-7 to protease treatment. Taken together, these results suggest that heparin may act as a carrier for IL-7, blocking its interaction with target cells and protecting it from degradation during transit.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589262     DOI: 10.1006/cyto.1995.0041

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Pulmonary delivery of interleukin-7 provides efficient and safe delivery to the aging immune system.

Authors:  Wayne A Mitchell; Aina Castells; Pierre Olivier Lang; Emmanuel Matas; Antonio Lapenna; Richard Aspinall
Journal:  Rejuvenation Res       Date:  2012-06-04       Impact factor: 4.663

Review 2.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

3.  Recycled IL-7 Can Be Delivered to Neighboring T Cells.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Soumya Panigrahi; Scott F Sieg
Journal:  J Immunol       Date:  2015-04-13       Impact factor: 5.422

Review 4.  Naive T cell homeostasis: from awareness of space to a sense of place.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

5.  IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.

Authors:  Sven Létourneau; Ester M M van Leeuwen; Carsten Krieg; Chris Martin; Giuseppe Pantaleo; Jonathan Sprent; Charles D Surh; Onur Boyman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

6.  Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity.

Authors:  Khue G Nguyen; Francis B Gillam; Jared J Hopkins; Srinivas Jayanthi; Ravi Kumar Gundampati; Guowei Su; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Barbara K Felber; Jian Liu; Suresh Kumar Thallapuranam; David A Zaharoff
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

7.  Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein.

Authors:  Rosendo Luria-Pérez; Pierre V Candelaria; Tracy R Daniels-Wells; José A Rodríguez; Gustavo Helguera; Manuel L Penichet
Journal:  Cytokine       Date:  2019-05-20       Impact factor: 3.861

8.  Structural determination of novel tetra- and hexasaccharide sequences isolated from chondroitin sulfate H (oversulfated dermatan sulfate) of hagfish notochord.

Authors:  C Ueoka; S Nadanaka; N Seno; K H Khoo; K Sugahara
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

Review 9.  Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.

Authors:  Inkyung Kang; Mary Y Chang; Thomas N Wight; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

10.  Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells.

Authors:  Masaharu Hatakeyama; Tadaatsu Imaizumi; Wakako Tamo; Koji Yamashita; Hidemi Yoshida; Ikuo Fukuda; Kei Satoh
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.